Source-linked transaction record
Rep. Debbie Wasserman Schultz's filing reports that a dependent child account purchased Keryx Biopharmaceuticals, Inc. (KERX) for the reported amount of $1,001 – $15,000. The filing identifies the account owner as dependent child.
Disclosures are reported transactions, not verified real-time portfolio holdings.
Same source document
Rep. Debbie Wasserman Schultz's filing reports that a dependent child account sold · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz's filing reports that a dependent child account sold · $1,001 – $15,000
View transaction details →Continue researching
Rep. Debbie Wasserman Schultz's filing reports that a dependent child account sold · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz's filing reports that a dependent child account purchased · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz's filing reports that a dependent child account purchased · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz disclosed that the filer sold · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz's filing reports that a dependent child account sold · $1,001 – $15,000
View transaction details →Rep. Debbie Wasserman Schultz's filing reports that a dependent child account sold · $1,001 – $15,000
View transaction details →